Delivery Order SPE2DB24D2011-SPE2DB25FBRRT
- Not listed
- The Defense Logistics Agency awarded a $4,002.34 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This is a firm fixed price, competitively awarded contract with a completion date of August 25, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA. The pharmaceutical product will be delivered to the vendor's primary location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $9,610.88 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $4,540.44 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a $8,835.12 delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract, issued on April 25, 2025, with an ultimate completion date of April 28, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive role as a pharmaceutical distributor supporting...
- The Defense Logistics Agency awarded a $5,247.80 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's established capability to fulfill federal pharmaceutical procurement requirements. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $4,540.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively...
- The Defense Logistics Agency awarded a $15,001.90 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $9,080.88 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA...
- The Defense Logistics Agency awarded a $62,369.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRRTDelivery Order
The Defense Logistics Agency awarded a $42,662.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This is a non-set-aside competitive award with a completion date of August 28, 2025, and performance location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement that runs through December 2026 and serves as the primary vehicle for pharmaceutical procurement supporting military healthcare systems globally. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills defense requirements across therapeutic domains including specialty medications, brand-name and generic drugs, and medical devices for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.7k | 8/27/25 |